A ROC analysis was carefully performed to fully evaluate BTBD19’s diagnostic potential in CRC (Figure 1E), suggesting it may act as a diagnostic biomarker to partly differentiate tumor states from normal conditions. This evidence concerns the gene BTBD19 and neoplasm.